To understand the functions of the activated RTKs for the growth of the KRAS or BRAF mutant CRC cells, the cells were treated with LAP, OSI, or JNJ individually or in combination based on the phospho-RTK patterns (Figure 4A and 4B). Here, KRAS is linked to colorectal carcinoma.